A major new insight into how Hepatitis B virus works could pave the way for new drug treatments for the infection, which is the major cause of liver cancer worldwide.
The team at the Universities of York and Leeds identified an “assembly code” in the genetic material of Hepatitis B virus that allows it to create a protective casing in which it can produce new infectious virus particles.
They found that the signal, generated by ribonucleic acid (RNA), helps viral proteins to overcome an ‘engineering problem’, assembling them into in a particular geometric pattern.
Molecular machine
Professor Reidun Twarock, mathematical biologist at the University of York’s Department of Mathematics and Biology, said: “It is a bit like the chain on a bicycle. If we don’t assemble the chain on the sprockets, it becomes tangled and won’t function. Once assembled correctly, it connects the pedals with the wheels allowing the component parts to work together.
“We see the same process happening between the Hepatitis B RNA signals and the viral proteins. The proteins are attracted by these signals, which then promote their assembly into a precise molecular machine that allows the virus to produce a DNA copy of its genetic material and hence become infectious.”
The virus is transmitted through blood and bodily fluids. It is thought that more than two billion people have been infected worldwide, and around 350 million people remain carriers of the infection, which can, over time, result in their deaths.
Potential drug
The virus occurs in Europe but is much more common in parts of Asia, especially China and Africa. There are more than one million infected people in the USA where treatments can include expensive drugs and even liver transplantation.
Professor Peter Stockley, a structural virologist from the University of Leeds Astbury Centre, said: “There is a vaccine for the virus, but once you have the condition there is no treatment, other than drugs that can reduce symptoms but not change the long-term outlook.
“We often compare the disease to HIV due to the way in which the virus is passed from person-to-person, but unlike HIV there are no effective drugs to improve quality of life outcomes. Now that we know how the virus assembles, we can interrupt the interactions with the RNA signals – a bit like when a twig catches the sprocket on a bike, knocking the chain off.”
Learn more: Scientists step closer to drug treatment for Hepatitis B
The Latest on: Hepatitis B
[google_news title=”” keyword=”Hepatitis B” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- 81K Bay Area residents with hepatitis B, mostly AAPI: CDCon April 30, 2024 at 3:29 pm
City officials were on the steps of City Hall Tuesday to declare May National Hepatitis Awareness Month. According to the CDC, hepatitis B has become the second leading infectious cause of death ...
- Entecavir for Chronic Hepatitis B in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2024-2032on April 30, 2024 at 3:53 am
The "Entecavir Market Size, Forecast, Insight - 2032" report has been added to ResearchAndMarkets.com's offering.A thorough market analysis on entecavir, a key pharmaceutical in the treatment of ...
- Unsafe Practices at Spa Put Clients at Risk for HIV, Hepatitison April 28, 2024 at 4:04 am
Researchers believe that spa activities may have transmitted HIV, hepatitis B, and C. Two HIV infections were found in 2019, likely connected to spa services. In 2023, the DOH's Infectious Disease ...
- Tests And Crackdowns On Hepatitis Outbreaks Triggered By Outbreakson April 28, 2024 at 3:29 am
There has been an alarming increase in the number of hepatitis cases in Rawalpindi’s Fauji Colony area. To protect residents from the growing health threat, extensive awareness and testing initiatives ...
- Calls for Hong Kong to offer hepatitis B screening to specific age groups in bid to eliminate viral infectionon April 27, 2024 at 2:11 pm
Screening may help to identify patients with condition that may not necessarily present symptoms, professor says.
- Stop hepatitis infection to curb increasing liver cancer cases —Otegbayo, UCH, chief medical directoron April 24, 2024 at 7:31 pm
In a bid to stop the hepatitis B virus, the leading cause of liver cancer, a liver expert, Professor Jesse Otegbayo, has stated the need to identify the factors that encourage the spread of hepatitis ...
- Get kids jabbed vs hepatitis B, lawmaker urges parentson April 19, 2024 at 6:50 am
House Deputy Majority Leader Janette Garin on Thursday urged parents to have their kids vaccinated against hepatitis B to protect them from liver cancer and possibly an outbreak by 2042. The ...
- World Liver Day: Hepatitis B is 50 to 100 times more infectious than HIVon April 19, 2024 at 3:14 am
HBV is spread by contact with the blood or body fluids of an infected person, the same way as the human immunodeficiency virus (HIV), according to the WHO. However, HBV is 50 to 100 times more ...
- World Liver Day: Prioritizing Viral Hepatitis Screening With Comprehensive Testingon April 18, 2024 at 11:05 pm
The primary reason to screen for Hepatitis B and C infection is to reduce morbidity and mortality associated with chronic liver disease and to curtail transmission.
- Hepatitis B Drug Pipeline Research Report 2024on April 18, 2024 at 8:45 am
The "Hepatitis B - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report outlays comprehensive insights of present clinical development scenario and ...
via Google News and Bing News